GLP-1 RA Use May Up Risk for Gallbladder, Biliary Diseases
THURSDAY, March 31, 2022 (HealthDay News) -- Use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with increased risks for gallbladder or biliary diseases, with a higher risk for GLP-1 RA use in weight loss, according to a review published online March 28 in JAMA Internal Medicine.
Liyun He, from the Peking Union Medical College Hospital in China, and colleagues conducted a systematic review of randomized controlled trials (RCTs) comparing the use of GLP-1 RA drugs with placebo or with non-GLP-1 RA drugs in adults to examine the association with gallbladder and biliary diseases. Data from 76 RCTs with 103,371 patients were included in the meta-analysis.
The researchers found that randomization to GLP-1 RA treatment among all included trials was associated with increased risks for gallbladder or biliary diseases (pooled relative risk [RR], 1.37), specifically cholelithiasis, cholecystitis, and biliary disease (RRs, 1.27, 1.36, and 1.55, respectively). GLP-1 RA use was associated with an elevated risk for gallbladder or biliary diseases in trials for weight loss (13 trials; RR, 2.29) and for type 2 diabetes and other diseases (63 trials; RR, 1.27). For all included trials, the risks for gallbladder or biliary diseases were higher with higher doses of GLP-1 RA use versus lower doses and for longer versus shorter duration of use.
"Physicians should be concerned about the increased risk of gallbladder or biliary disease associated with GLP-1 RA use, especially at the higher doses recommended for weight loss," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Related Posts
Oocyte Retrieval in Summer Linked to Increased Odds of Live Birth
FRIDAY, July 7, 2023 (HealthDay News) -- Oocytes retrieved in the summer and on...
China afloja sus normas para viajar mientras levanta las restricciones por la COVID
MIÉRCOLES, 28 de diciembre de 2022 (HealthDay News) -- China planifica reducir...
Pandemic Lockdowns, Closures Tough on People With Disabilities
TUESDAY, June 27, 2022 (HealthDay News) -- When the early days of the pandemic...
Salsa para la inteligencia: el baile latino podría potenciar al cerebro que envejece
VIERNES, 17 de junio de 2022 (HealthDay News) -- Unas clases de baile latino...